PERIOPERATIVE THERAPY WITH GEMCITABINE/CISPLATIN/NAB-PACLITAXEL AND
RILVEGOSTOMIG (AZD2936) FOR PATIENTS WITH RESECTABLE INTRAHEPATIC
CHOLANGIOCARCINOMA (ICCA) - A PHASE II TRIAL (NEOLANGIO)
- Registry ID
- NEOLANGIO
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Phase
- PHASE2
- Study type
- INTERVENTIONAL
- Sponsor
- UNIVERSITY HEALTH NETWORK
- Start date
- 2026-03-25
- Last update
- 2025-05-08
Conditions
- INTRAHEPATIC CHOLANGIOCARCINOMA
View on source registry